The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 1,273,997 | 1,377,294 | SH | OTR | 1,2,3 | 0 | 1,377,294 | 0 | |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 10,479,346 | 11,086,909 | SH | OTR | 1,2,3 | 0 | 11,086,909 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 50,805,453 | 21,346,829 | SH | OTR | 1,2,3 | 0 | 21,346,829 | 0 | |
FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 3,783,591 | 1,466,508 | SH | OTR | 1,2,3 | 0 | 1,466,508 | 0 |